Sanofi(SNY) To Spin Off Active Pharmaceutical Ingredients Business

With coronavirus beginning its worldwide spread in February, France’s Sanofi (SNY) revealed plans to spin off its active pharmaceutical ingredients (API) business into a standalone company. For the sake of layman like us, APIs are the ‘magic’ molecules that make drugs work and according to Sanofi, the vast majority of APIs are currently manufactured in Asia (ex China… Read More »